Keith Lerner of Truist Advisory Services says the S&P 500’s upside is limited to 5% near-term, but the downside could be 10%.
Pfizer sticks to 2025 profit view as it shrugs off plunging Paxlovid sales for COVID
Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
